ReviewWorld journal of gastrointestinal surgery2025
Advancements in endoscopic resection of gastrointestinal stromal tumors: Techniques, outcomes, and perspectives.
Review in World journal of gastrointestinal surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Development and validation of a risk prediction model for piecemeal resection during endoscopic resection of gastric GISTs.Surgical endoscopy · 2026Article
- 15-year ultra-late presentation of bifocal hepatic metastasis from gastrointestinal stromal tumor: a case report.Frontiers in surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract and arise from the interstitial cells of Cajal. They predominantly affect individuals between 50 and 70 years of age and often carry malignant potential despite being frequently asymptomatic. The stomach and small intestine are the most common locations, while involvement of the esophagus, colon, or rectum is relatively rare. GISTs are often discovered incidentally during endoscopic or radiologic evaluations, and the diagnosis is confirmed through tissue biopsy and immunohistochemical staining, particularly for KIT (CD117), DOG1, and PDGFRA. In the past decade, laparoscopic resection has been considered the standard treatment for localized GISTs smaller than 5 cm. However, recent advances in endoscopic technology have led to a growing role for endoscopic resection as a safe and effective treatment option for selected nonmetastatic GISTs. Endoscopic techniques such as endoscopic submucosal dissection, endoscopic submucosal excavation, submucosal tunneling endoscopic resection, and endoscopic full-thickness resection have demonstrated favorable outcomes, including high complete resection (R0) rates, shorter hospital stays, and quicker recovery compared to traditional surgery. The selection of an appropriate resection method depends on tumor size, location, depth of invasion, and proximity to vital structures. Endoscopic ultrasound has become an essential tool for preprocedural assessment, providing detailed information on tumor characteristics and helping to guide management decisions. While endoscopic resection is a promising minimally invasive approach, it should be performed by skilled endoscopists with appropriate training due to the technical complexity and risk of complications such as bleeding or perforation. This review summarizes recent developments in endoscopic resection of GISTs, with a focus on indications, procedural safety, clinical outcomes, and recommendations for optimal patient selection and procedural planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.